SyntekaBio Statistics

Total Valuation

SyntekaBio has a market cap or net worth of KRW 86.82 billion. The enterprise value is 74.10 billion.

Market Cap	86.82B
Enterprise Value	74.10B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

SyntekaBio has 15.26 million shares outstanding. The number of shares has increased by 10.75% in one year.

Current Share Class	n/a
Shares Outstanding	15.26M
Shares Change (YoY)	+10.75%
Shares Change (QoQ)	+13.79%
Owned by Insiders (%)	17.29%
Owned by Institutions (%)	1.90%
Float	12.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.98
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.27

Financial Position

The company has a current ratio of 1.10, with a Debt / Equity ratio of 0.22.

Current Ratio	1.10
Quick Ratio	1.04
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-0.31
Interest Coverage	-16.98

Financial Efficiency

Return on equity (ROE) is -22.07% and return on invested capital (ROIC) is -19.38%.

Return on Equity (ROE)	-22.07%
Return on Assets (ROA)	-14.59%
Return on Capital (ROIC)	-19.38%
Revenue Per Employee	1.97M
Profits Per Employee	-117.79M
Employee Count	63
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.21% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.21%
50-Day Moving Average	5,616.90
200-Day Moving Average	8,543.58
Relative Strength Index (RSI)	54.71
Average Volume (20 Days)	155,138

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SyntekaBio had revenue of KRW 124.38 million and -7.42 billion in losses. Loss per share was -899.75.

Revenue	124.38M
Gross Profit	121.82M
Operating Income	-12.80B
Pretax Income	-7.42B
Net Income	-7.42B
EBITDA	-10.72B
EBIT	-12.80B
Loss Per Share	-899.75

Full Income Statement

Balance Sheet

The company has 19.75 billion in cash and 7.02 billion in debt, giving a net cash position of 12.72 billion or 833.83 per share.

Cash & Cash Equivalents	19.75B
Total Debt	7.02B
Net Cash	12.72B
Net Cash Per Share	833.83
Equity (Book Value)	31.63B
Book Value Per Share	2,073.02
Working Capital	1.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.75 billion and capital expenditures -13.88 billion, giving a free cash flow of -22.64 billion.

Operating Cash Flow	-8.75B
Capital Expenditures	-13.88B
Free Cash Flow	-22.64B
FCF Per Share	-1,483.53

Full Cash Flow Statement

Margins

Gross Margin	97.94%
Operating Margin	-10,288.07%
Pretax Margin	-5,966.30%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-18,198.95%

Dividends & Yields

SyntekaBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.75%
Shareholder Yield	-10.75%
Earnings Yield	-15.81%
FCF Yield	-26.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SyntekaBio has an Altman Z-Score of 2.41. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.41
Piotroski F-Score	n/a